Advanced Analytics. Intelligent Insights.

Your medical imaging partner, we support biopharmaceutical companies across all phases of CNS clinical research.

News

Publications

Blog

Careers at IXICO

Commercial agreement with PETNET Solutions Inc, a Siemens Healthineers Company

16 December 2024 - London, UK. IXICO plc (AIM: IXI, “IXICO” or “the Company”) a global leader in neuroscience imaging, using its AI-driven platform to help advance therapy research in neurological disorders, today announced a commercial agreement with PETNET Solutions Inc, a Siemens Healthineers company (“PETNET”) to supply diagnostic imaging agents to IXICO. This new offering is an integral part of IXICO’s expansion strategy to serve its growing customer base with the latest technologies in neuroimaging.

Fully automatic detection and quantification of new white matter lesions using deep learning

Accurate detection, segmentation, and quantification of lesion dynamics in longitudinal MRI is crucial for monitoring disease progression in Multiple Sclerosis, and for evaluating the efficacy of therapeutic interventions. We present an efficient, automatic method utilising deep learning to assess lesion changes in FLAIR MRI with a high degree of accuracy.

Alzheimer's Disease: The Role of Cutting-Edge Neuroimaging Techniques

Alzheimer's disease is a complex neurodegenerative disorder that affects millions of people worldwide. While there is no cure for the disease, ongoing research efforts have led to significant advancements in our understanding of the underlying mechanisms that drive the disease.

Imaging Scientist

Consultancy

We can work with you on the selection and use of medical imaging and digital biomarkers for your drug development programs, directly and as part of collaborative consortia.

Early Phase

We are experts in the definition and delivery of early phase clinical development, where rigorous patient safety runs hand-in-hand with flexibility around trial design and data analytics.

Late Phase

Our global network of over 2,000 imaging centers across 75 countries ensures large-scale trials can be set up quickly and efficiently, while our custom TrialTracker platform delivers highly reliable, regulatory compliant data.

Post-Marketing

We understand the challenges of extended longitudinal studies. We support you to monitor patient safety and drug utilization for ongoing optimization of patient pathways post-marketing.

Specialist Therapeutic Focus

We have focused exclusively on neurological disorders since 2004, and our growing team are renowned experts in CNS therapeutics. We combine specialist neuroscience knowledge, highly curated neurological patient data and proven pipeline algorithms to accurately measure brain biomarkers.

Our world-class therapeutic expertise, breakthrough technology and analytics, and operational excellence makes us the partner of choice for imaging biomarker solutions in CNS clinical trials.

The diseases we work on include:

01

Imaging Biomarkers

We are at the forefront of developing and validating unique neuroimaging methods and MRI and PET image analysis techniques. This enables us to provide you with accurate, rich structural and functional information.

02

Analytics & AI

In neuroscience, AI has applications across the entire spectrum of understanding and treating disease. Our sophisticated AI technology and analytics support your clinical development programmes by interpreting complex patient data into valuable insight.

03

Data Platforms

Our fully compliant image and digital data management provides everything you need to manage complex data workflows in CNS clinical trials. Our secure online digital platform supports your clinical decision-making, from patient selection to post-marketing surveillance.

Get the latest content from IXICO

Sign up below and we'll send you the latest insight, knowledge and innovations from IXICO to your inbox.

Subscribe to content

Advanced Analytics. Intelligent Insights.